Will the FDA approve intismeran autogene (V940/mRNA-4157)?
Sep 4, 2027even chance by
- Before Apr 1, 20274%
- Before Jul 1, 202714%
- Before Oct 1, 202766%
2 more
- Before Jan 1, 202888%
- Before Jul 1, 202895%
Install
Will the FDA approve MDMA for PTSD?
The odds
Oct 20, 2028even chance by
- Before Jan 1, 202710%
- Before Jan 1, 202842%▲ 7
- Before Jan 1, 202952%
- Before Jan 1, 203053%
- Before Jan 1, 203153%
- Before Jan 1, 203253%
How the odds have moved
Before Jan 1, 2028: 35% on Oct 20, 42% now.
Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.
Every outcome
| Outcome | Chance | Day | Bid | Ask | Pays | Contracts |
|---|---|---|---|---|---|---|
| Before Jan 1, 2027 | 10% | 6¢ | 13¢ | $7.69 | 1.3K | |
| Before Jan 1, 2028 | 42% | ▲ 7 | 39¢ | 45¢ | $2.22 | 1.3K |
| Before Jan 1, 2029 | 52% | 49¢ | 55¢ | $1.82 | 2.6K | |
| Before Jan 1, 2030 | 53% | 50¢ | 56¢ | $1.79 | 3.5K | |
| Before Jan 1, 2031 | 53% | 51¢ | 57¢ | $1.75 | 2.8K | |
| Before Jan 1, 2032 | 53% | 51¢ | 52¢ | $1.92 | 2.2K |
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
The news: FDA, MDMA, PTSD
Search ›- Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in AustraliaBatch sufficient to supply the proposed Canadian Phase 3 trial, a clinical trial in Israel in partnership with MAPS and a commercial export to treat PTSD in Australia Health Canada-authorized trial to evaluate efficacy and safety of two…
-
FDA allowing food companies to switch to salt substituteCBS News FDA allowing food companies to switch to salt substitute Chicago still accepting submissions for official 2026 Christmas tree Metra UP-NW train hits vehicle in Des Plaines, delays service Expert weighs in after nearly 1,000 birds… -
Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugsCheaper copycat versions of the popular weight-loss drugs Wegovy and Zepbound are still being marketed to consumers. The thriving market for "compounded" GLP-1 medications persists despite warnings from federal drug regulators, a recall… -
Held at gunpoint at 19, father-of-two still living with PTSD 19 years laterLuke Walter said being held at gunpoint during a 2007 robbery continued to affect him nearly 20 years later Nearly 20 years after a gunman held a weapon to his head during a robbery, Luke Walter says the fear has never completely gone… -
Dr. Scott Gottlieb on FDA's Rare Disease Framework, measles outbreak latest and rise of peptidesFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the launch of FDA's Rare Disease Framework Initiative, latest developments in the measles outbreak, his thoughts on peptides, and more. Dr. Scott Gottlieb on FDA's… -
Sensing Data Toolkit Helps Improve Therapy for Veterans with PTSDNewswise — Clinical psychologists who treat post-traumatic stress disorder (PTSD) could soon gain better insight into how their patients experience triggering environments and situations outside the clinic. Cognitive behavioral therapies… -
The FDA is stepping up against breast cancerWashington Examiner is a news organization based in Washington, D.C., covering Congress, the White House, national security, the courts and elections, with breaking news, investigative reporting and conservative analysis. It publishes a… -
New $1.2 Million NSF Grant Aims to Improve Treatment for PTSD Patients“PECSS will allow clinicians to use automated predictions to deliver better therapeutic treatment and individualized feedback, and patients to better understand the progress they are making and how to improve their exposure exercises,”… - No PTSD, Expert Says In Ex-SF DA Worker's Racial Slur TrialLaw360 No PTSD, Expert Says In Ex-SF DA Worker's Racial Slur Trial To view the full article, register now.
-
Duty Calls: New PTSD service dog training site to openJake Oreshan, a retiree of the state Office of Fire Prevention and Control, meets his PTSD service dog, Iri. Amy Bergstrom, a Navy veteran, stands with her PTSD service dog, Barnabas. The new training space for the Ibi Semper Training… -
Can traumatic stress from COVID lead to PTSD?"Although COVID-19 has not impacted all people equally or in the same ways, it is a unique shared experience," says Jeff Ashby. "We are all compromised by this prolonged and ongoing traumatic stress, even if we haven't experienced PTSD."… - Louisville dance group supports wellness in veterans with PTSD, traumatic brain injuriesIn an old Highlands gym, under the gentle glow of string lights and waning sunlight, a group of veterans and their loved ones sashayed in a coordinated routine. A piano and fiddle duet set the tempo and dance instructor Deborah Denenfeld…
Related markets
All fda & drugs ›Will the FDA approve CagriSema?
68%Before Jan 1, 2027
- Before Jan 1, 202768%▼ 1
- Before Jul 1, 202793%
- Before Jan 1, 202893%
Will the FDA approve cytisinicline for smoking cessation?
39%Before Jul 1, 2027
- Before Jan 1, 202712%
- Before Jul 1, 202739%
When will the FDA approve Compass Pathways' COMP360 Psilocybin? (COMP360 Psilocybin for Treatment-Resistant Depression)
88%Before 2028
- Before 202888%
- Before July 202785%
- Before October 202785%▲ 1
2 more
- Before Mar 1, 202762%
- Before Jan 1, 202728%▲ 5
When will the FDA reclassify BPC-157 to Category 1?
21%Before 2027
- Before 202721%▼ 6
- Before November7%▲ 1
Will the FDA approve retatrutide? (retatrutide (LY3437943))
Oct 22, 2027even chance by
- Before Jan 1, 20274%
- Before Jul 1, 202718%
- Before Jan 1, 202871%
2 more
- Before Jul 1, 202885%
- Before Jan 1, 202990%
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Search. Prices read from the venues 2 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Search, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Search index; prices of stocks, rates and coins from 4Search Finance. Nothing here is betting, financial or investment advice. Terms of use.